Cellular Biology |
From the Centre for Clinical Pharmacology, Department of Medicine, University College London, UK.
Correspondence to Dr Lucie H. Clapp, Centre of Clinical Pharmacology, Department of Medicine, University College London, 5 University St, London WC1E 6JJ, UK. E-mail l.clapp{at}ucl.ac.uk
| Abstract |
|---|
|
|
|---|
-40 mV when bathed in
1.8 mmol/L Ca2+. The
KATP channel inhibitor glibenclamide caused
membrane depolarization (9 mV) and inhibited a small, time-independent
background current. Reducing [ATP]i from 3 to
0.1 mmol/L hyperpolarized cells to
-60 mV and increased
glibenclamide-sensitive current by 2- to 4-fold. Similar effects were
observed when Ca2+ levels were decreased
either externally or internally by increasing EGTA from 1 to 10 mmol/L.
Dialysis with solutions containing different free
[Ca2+]i showed that
KATP current was maximally activated at 10
nmol/L [Ca2+]i and
almost totally inhibited at 300 nmol/L. Moreover, under control
conditions, when rat aortic smooth muscle cells were dialyzed with
either cyclosporin A, FK-506, or calcineurin autoinhibitory peptide
(structurally unrelated inhibitors of
Ca2+-dependent protein phosphatase, type
2B), glibenclamide-sensitive currents were large and the resting
potential was hyperpolarized by
20 to 25 mV. We report for the first
time that KATP channels can be modulated by
Ca2+ at physiological
[ATP]i and conclude that modulation occurs via
protein phosphatase type
2B.
Key Words: calcium KATP channel protein phosphatase-2B smooth muscle whole-cell recording
| Introduction |
|---|
|
|
|---|
Vascular KATP channels are inhibited at a half-maximal concentration of intracellular ATP ([ATP]i) of between 10 and 300 µmol/L,1 and because [ATP]i in arterial smooth muscle is on the order of 1.5 to 3 mmol/L,4 it is anticipated that these channels would normally be closed under physiological conditions. However, several reports show that glibenclamide depolarizes intact blood vessels5 6 or isolated cells in the perforated patch configuration7 in vitro and decreases resting blood flow in vivo.8 These observations suggest that KATP channels are open and do indeed contribute to the resting membrane potential and maintenance of arterial tone in some smooth muscles.1 Moreover, other factors, including various protein kinases, are known to regulate the activity of these channels presumably by controlling the degree of phosphorylation of the channel itself or a closely associated protein.1 9
Classically, KATP channels have been investigated under conditions where [Ca2+]i is buffered to low levels and external Ca2+ ([Ca2+]o) has been removed. Such conditions have been used primarily because several single-channel studies1 have indicated that KATP channels are insensitive to Ca2+ but also to minimize the activity of Ca2+-dependent K+ and chloride channels. To our knowledge, there has been only one report to date of Ca2+ modulation of KATP channels in freshly isolated smooth muscle cells, where a small conductance channel activated by micromolar [Ca2+]i and inhibited by [ATP]i was observed in excised patches in rat portal vein.10 In cultured porcine coronary myocytes, KATP channels with a high activity at a physiological [Ca2+]o have been described,2 although such a channel has not been reported in freshly isolated cells.1 Whether Ca2+ regulates KATP channels in intact cells, where cytosolic regulatory processes would be preserved, remains to be determined. Therefore, the present study was designed to investigate the effects of [Ca2+] on whole-cell KATP current under a physiological [ATP]i in isolated rat aortic smooth muscle cells (RASMCs).
| Materials and Methods |
|---|
|
|
|---|
when filled with solution containing, in mmol/L, KCl 135,
MgCl2 1.2, EGTA 1 or 10, HEPES 10, MgATP 0.1 or
3, and NaGTP 0.5 (pH 7.2 with KOH). Pipette solutions with known free
[Ca2+] (1 to 300 nmol/L) were prepared by
adding specified volumes of CaCl2 (CaBuf
software) to the 10 mmol/L EGTA pipette solution. RASMCs were
continuously superfused with bath solution or drugs applied by pressure
ejection from a multibarreled micropipette placed 500 µm from the
cell. Membrane potential and whole-cell currents were recorded under current or voltage clamp in the whole-cell configuration of the patch-clamp technique. Unless stated, all recordings were made at least 5 minutes after gaining cell access. Currents were recorded using either 100-ms depolarizing voltage steps of 10-mV increments (every 10 seconds) from -90 to +40 mV elicited from a holding potential of -80 mV or voltage ramps from -100 to +40 mV at a rate of 0.0875 V/s in cells held at -60 mV. The difference current was acquired by digital subtraction of the current trace obtained at the maximal effect of a given manipulation from its corresponding control.
Cyclosporin A, FK-506, and calcineurin autoinhibitory peptide were obtained from Affiniti-Research Products. All data are expressed as mean±SEM from n cells. Statistical difference between groups was calculated using either paired or Students unpaired t test. For multiple comparisons, a 1- or 2-way ANOVA with Bonferroni or Student-Newman-Keuls correction methods were used. A value of P<0.05 was considered statistically significant.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
|
|
To additionally characterize the background current, we
assessed the effects of lowering [ATP]i from 3
to 0.1 mmol/L. Such manipulations have previously been shown in many
smooth muscle cell types to activate or enhance whole-cell
KATP current and responses to
KATP channel
openers.1 12
Dialysis with 0.1 mmol/L [ATP]i caused a large
increase in the magnitude of the background current
(Figure 1C
), and cells were significantly more hyperpolarized
(
17 mV; P<0.001) compared
with 3 mmol/L [ATP]i
(Table 1
). Superfusion with levcromakalim also caused a
larger hyperpolarization (16.9±2.2 mV; n=6,
P<0.001) and a greater
increase in current
(Figures 1B
and 1D
). Indeed, the magnitude of the
glibenclamide-sensitive current
(IGlib)
and levcromakalim-sensitive current
(ILev)
(Figure 1E
) were 2.5- to 3-fold larger in 0.1 compared with 3
mmol/L [ATP]i. For example, at +10 mV,
IGlib
increased from 33.8±6.1 pA (n=11) to 90.5±19.8 pA (n=5). Consistent
with effects on K+ currents, the reversal
potential of
IGlib
and ILev
was -77.6±1.2 mV (n=5) and -77.1±1 mV (n=6), respectively
(Figure 1D
), which is close to the predicted potassium
equilibrium potential (EK) under our recording
conditions of -80.4 mV.
Modulation of Whole-Cell
K+ Current by
Ca2+
To assess the effects of
Ca2+ on whole-cell
K+ current and membrane potential, 2 sets of
experiments were performed. Firstly,
[Ca2+]o was lowered
to nominally Ca2+-free (0
[Ca2+]o), and
secondly, [Ca2+]i
was reduced by increasing the [EGTA]i from 1
to 10 mmol/L. All other conditions remained the same. In 0
[Ca2+]o, the
magnitude of instantaneous background current was significantly
increased at all potentials
(Figure 2A
) when compared with control conditions
(Figure 1A
). This was associated with a 20 mV membrane
hyperpolarization (P<0.001,
Table 1
). Moreover, the resting potential remained stable,
measuring -59.1±3.5 mV (n=8) and -55.1±3.2 mV (n=6) after 15 and
40 minutes of recording, respectively. Superfusion of glibenclamide (10
µmol/L) caused a complete inhibition of the increase in background
current
(Figure 2A
) and reversed membrane hyperpolarization
(Figure 3C
). Furthermore, glibenclamide had no effect on
time-dependent currents, which were apparent at positive potentials
(Figure 2A
). Similar results were also observed in cells
bathed with HBSS containing 0.1 mmol/L Ca2+
(data not shown).
|
In another set of experiments, RASMCs dialyzed with 10
mmol/L [EGTA]i displayed a current-voltage
(I-V) relationship similar to
that obtained for the 0
[Ca2+]o condition
(Figures 2B
and 3A
). Under these conditions, the background
current became the predominant current observed. The appearance of this
current was associated with similar membrane hyperpolarization to that
recorded in 0
[Ca2+]o
(Table 1
). In addition, the background current was highly
sensitive to block by glibenclamide
(P<0.001,
Figures 2B
and 3B
), with 3 µmol/L inhibiting the
instantaneous current measured from the
I-V at 0 mV by 80% from
99.6±24.2 pA to 21.9±2.6 pA (n=10). This was associated with
significant membrane depolarization
(Figure 3C
).
When comparing the mean instantaneous
I-V relationships for the 3
different Ca2+ conditions
(Figure 3A
), there was significantly
(P<0.05) less instantaneous
current in 1.8 mmol/L
[Ca2+]o and 1
mmol/L [EGTA]i compared with the low
Ca2+ recording conditions. This is
consistent with the observation that the magnitude of
IGlib
was significantly less in control cells compared with recordings in 10
mmol/L [EGTA]i or 0
[Ca2+]o
(Figure 3B
). For example, at 0 mV, the size of
IGlib
under control conditions was 20.2±6.7 pA (n=11) and with 10 mmol/L
[EGTA]i was 80.1±20.9 pA (n=10).
To estimate the
[Ca2+]i range that
regulates KATP current, RASMCs were dialyzed
with solutions containing different free
[Ca2+]i (1 to 300
nmol/L) and superfused with 1.8 mmol/L Ca2+.
With 1 nmol/L
[Ca2+]i, RASMCs
displayed voltage-ramp currents that were almost entirely inhibited by
glibenclamide
(Figure 4A
), with the size of
IGlib at
+10 mV being similar (89.3±10 pA, n=14) to that recorded from ramps in
either the 0
[Ca2+]o (85.6±11
pA, n=9) or 10 mmol/L [EGTA]i (88.7±18 pA,
n=9) condition. However, with 300 nmol/L
[Ca2+]i, the
I-V relationship was
substantially altered, with little current being activated at negative
potentials. At positive potentials, current activated steeply and was
noisy in appearance, being several hundred pA in size at +40 mV. This
current was largely unaffected by glibenclamide
(Figure 4B
),
IGlib
being only 16.6±3.9 pA (n=8) at +10 mV, but it was almost completely
inhibited by 300 nmol/L paxilline
(Figure 4B
), a potent inhibitor of the large-conductance
Ca2+-activated K+
(BKCa)
channel.13 In contrast,
paxilline had only a small effect on currents recorded in 1 nmol/L
[Ca2+]i
(Figure 4A
) or 0
[Ca2+]o (see Figure 2
online), nor did it affect resting membrane potential in low
[Ca2+]o (<300
nmol/L; see Figure 2
online). These latter results suggest that
BKCa channels do not contribute to the resting
potential, as has been observed in many smooth muscle
types.14 15 The
averaged voltage-ramp data for
IGlib
under the different Ca2+ conditions is shown
in
Figure 4C
, where current has been normalized to cell size.
Analysis reveals that the magnitude of
IGlib is
negatively correlated to the free
[Ca2+]i
(Figure 4D
), whereas the magnitude of the paxilline-sensitive
current
(IPax)
was enhanced by increasing
[Ca2+]i
(Figure 4E
). Maximal activation of
IGlib
occurred between 1 and 10 nmol/L
[Ca2+]i and was
reduced by
50% at 100 nmol/L and
90% at 300 nmol/L. Unlike
IGlib,
there was no significant difference in the magnitude of
IPax at
+10 mV in any
[Ca2+]i tested,
although at +40 mV, a substantial increase in
IPax was
observed (P<0.001) with 300
nmol/L Ca2+ compared with lower
[Ca2+]i
(Figure 4E
).
|
The mean resting potentials of RASMCs in 1 to 10 nmol/L
Ca2+ were similar to 0
[Ca2+] and 10 mmol/L EGTA conditions
(Tables 1
and 2
), as were the effects of glibenclamide on
membrane potential
(Table 2
and
Figure 3C
). At 100 nmol/L
[Ca2+]i, cells
still had a resting potential of -57 mV, although they became
substantially more depolarized (-32 mV) at 300 nmol/L, where
glibenclamide did not produce any significant depolarization
(Table 2
).Thus, whole-cell KATP
current and resting potential are steeply dependent on
[Ca2+]i in a range
that is close to resting
[Ca2+]i recorded in
smooth muscle of between 100 and 200
nmol/L.16
|
Effects of
Ca2+-Dependent
Protein Phosphatase-2B Inhibitors
Because lower Ca2+
concentrations seemed to enhance KATP channel
activity, in a separate group of experiments, we assessed the
possibility that a Ca2+-dependent enzyme may
be involved in the modulation of channel activity. It has been shown
previously that L-type Ca2+ channels can be
inhibited by intracellular Ca2+ via
activation of calcineurin, the
Ca2+-dependent protein phosphatase, type 2B
(PP-2B),17 an enzyme known
to be present in RASMCs.18
These results suggest that a dephosphorylating event causes
Ca2+ channel inactivation to occur. Applying
the same principle to our study, we postulated that under conditions
where the [Ca2+]i
is low, the activity of PP-2B would be concomitantly reduced, leading
to enhanced activity of KATP channels through
increased phosphorylation of the channel.
Under control recording conditions of 3
[ATP]i, 1 [EGTA]i,
and 1.8 [Ca2+]o,
where there was usually little background current, dialysis of RASMCs
with cyclosporin A (10 µmol/L), an inhibitor of
PP-2B,19 caused an increase
of an instantaneous background current
(Figure 5A
), which was similar to that observed in the low
[Ca2+] conditions
(Figure 2
). This increase was associated with significant
membrane hyperpolarization from -42.0±2.7 mV at
30 seconds after
gaining cell access to -58.6±1.6 mV after 5 minutes (n=9;
P<0.001). This effect could be
reversibly inhibited by glibenclamide (10 µmol/L)
(Figure 6A
). Furthermore, cyclosporin A induced an
3-fold
increase in
IGlib
over control conditions
(Figure 6B
). To confirm the specificity of cyclosporin A on
PP-2B, we also investigated the effects of 2 structurally unrelated
PP-2B inhibitors, FK-50620
and the highly selective inhibitor calcineurin autoinhibitory peptide
(CAP).21 In 4 of 8 cells,
dialysis with FK-506 (5 to 10 µmol/L) for at least 5 minutes was
associated with increased background currents
(Figure 5B
) and a significant hyperpolarization of the
resting membrane potential (-57.6±5.9 mV, n=4). Again, this
hyperpolarization was inhibited by glibenclamide
(Figure 6A
), and the magnitude of
IGlib
was large
(Figure 6B
). With FK-506, the experiments were performed in
the presence of paxilline (250 nmol/L), because we observed significant
activation of BKCa current with this agent.
Dialysis with CAP (10 µmol/L), like cyclosporin A, resulted in every
cell tested becoming significantly hyperpolarized with time. The
resting potential of cells was -31.8± 2.5 mV immediately on
gaining cell access and hyperpolarized to -62.3±1.3 mV after 10
minutes (n=18; P<0.001),
remaining stable for several minutes thereafter. This is in contrast to
control cells, where the resting potential remained close to -40 mV
during the first 5 minutes of recording (see above) and declined
subsequently in a number of cells. Not only did glibenclamide cause
substantial depolarization (33 mV) with CAP
(Figure 6A
), but we tended to record the largest basal
KATP currents in this condition
(Figure 5C
).
|
|
| Discussion |
|---|
|
|
|---|
The background current was identified as being carried by KATP channels on the basis of the following criteria. First, it was inhibited by glibenclamide in the low micromolar range, and IGlib reversed within 5 mV of the predicted EK under our recording conditions. It was essentially unaffected by paxilline, suggesting that the background current was not carried by BKCa channels. Second, the background current was sensitive to changes in [ATP]i and increased in magnitude when [ATP]i was lowered from 3 to 0.1 mmol/L. Third, the size of the levcromakalim-sensitive background current was larger when ATP was reduced in the pipette. These are very similar pharmacological characteristics to KATP current recorded in isolated cells from many smooth muscle types.1 However, at this stage the molecular identity of the KATP channel subtype modulated by Ca2+ in rat aorta is unclear. Whether the whole-cell current is carried by glibenclamide-sensitive, nucleotide diphosphate K+ channels22 23 or the more classical type of KATP channel1 23 24 remains to be determined.
To our knowledge, the few studies that have assessed the Ca2+ sensitivity of KATP channels in excised patches or lipid bilayers have either reported no effect25 26 27 over the [Ca2+] range of 10 to 1000 nmol/L or an increase in activity above this concentration.2 10 26 In cultured porcine coronary myocytes, the sensitivity of channels to [ATP]i was reported to decrease when [Ca2+]o was raised from 1 to 100 µmol/L.2 Our experimental observations are clearly different from all previous studies, because we report regulation in the opposite direction. Our findings are analogous to the situation in cardiac and skeletal myocytes, where KATP channels have a high activity when excised into Ca2+-free solutions but can be inhibited when Ca2+ is applied to the internal surface of the channel.28 29 However, the Ca2+ concentrations required to inhibit the channel are much higher (>10 µmol/L) than we estimate for our internal solutions. Although it is clearly difficult to predict the subsarcolemmal [Ca2+], we assume it to be higher than cytosolic Ca2+ levels, particularly in cells recorded under control conditions (1.8 mmol/L Ca2+ and 1 mmol/L EGTA). On the basis of the comparison of IGlib recorded with pipette solutions of known [Ca2+]i, we estimate that the [Ca2+] in the vicinity of channel is between 100 and 300 nmol/L in control cells and between 1 and 10 nmol/L for the low Ca2+ conditions (10 mmol/L [EGTA]i and 0 [Ca2+]o). However, it remains to be determined whether similar Ca2+ modulation or sensitivity of KATP channels can be observed in isolated patches. This is likely to be extremely difficult to assess because of the rapid run down and low density of KATP channels in smooth muscle.1 Moreover, channel regulation may well be different in excised patches because of the absence of the intracellular matrix and cytosolic regulatory proteins. Thus, our results suggest that the level of Ca2+ buffering should be considered when studying KATP channels. Indeed, the differences in the ATP sensitivity of smooth muscle KATP channels that is observed experimentally1 may well be related to different starting levels of Ca2+.
Evidence suggests that the activity of vascular KATP channels is governed by the degree and the site of phosphorylation and dephosphorylation.1 14 Clearly, [Ca2+]i level plays an important role in regulating the activity of many Ca2+-dependent or -activated proteins in the cells, such as Ca2+-dependent protein kinase C (PKC) isoforms, Ca2+/calmodulin-dependent protein kinase II, and PP-2B.16 19 In smooth muscle cells, KATP channels can be opened by vasodilators stimulating protein kinase A (PKA) and closed by vasoconstrictors stimulating PKC.1 14 However, the effects of protein phosphatases on the modulation of KATP channel activity in smooth muscle by PKA and PKC is far from clear. In gallbladder smooth muscle cells, PKA-mediated activation of KATP by calcitonin generelated peptide was shown to persist after treatment with okadaic acid (an inhibitor of Ca2+-independent PP-1 and PP-2A), suggesting that PP-1 and PP-2A dephosphorylate a PKA phosphorylation site.3 Similarly, okadaic acid was shown to prevent cardiac KATP channel rundown30 and preserve PKC-induced KATP activation.31 Because these effects could be reversed by purified PP-2A, these studies suggested that PP-2A is responsible for dephosphorylating a PKC phosphorylation site. So far, the specific contribution of PP-2B to smooth muscle KATP channel regulation has not been investigated, although PP-2B protein or activity has been described in many cell types,19 suggesting that this enzyme may have important functional roles.
In this study we demonstrated that PP-2B is likely to be
involved in the modulation of KATP channels by
Ca2+. Dialysis with the highly selective
PP-2B inhibitor, CAP, which has an IC50 of
5
µmol/L against PP-2B,21
activated a large glibenclamide-sensitive current and significantly
hyperpolarized the resting potential in control cells. This synthetic
peptide is derived from a unique sequence in the autoinhibitory domain
of calcineurin and has been reported to have a high degree of
specificity for this enzyme, having no significant inhibitory effect on
PP-1 or PP-2A or Ca2+/calmodulin-dependent
protein kinase II.32 The
specificity of this agent was additionally tested using 2 other
structurally unrelated PP-2B inhibitors, cyclosporin A and FK-506,
which inhibit the enzyme by first forming a complex with either
cyclophilin A or FKBP12,
respectively.20 Both these
inhibitors had effects similar to CAP, increasing whole-cell
KATP current. However, we found that FK-506, and
to a much lesser extent cyclosporin A, increased
BKCa current, consistent with the known ability
of FK-506 to increase
[Ca2+]i in bladder
or A7r5 cells either by inhibiting the sarcoplasmic reticulum
Ca2+ATPase or increasing
Ca2+ release from the ryanodine
receptor.33 34
The effects of the PP-2B inhibitors on the
KATP current and membrane potential that we
observed were mimicked by recording current in low
[Ca2+]i (1 to 10
nmol/L). At this concentration, the activity of this enzyme should be
negligible.19 Half-maximal
activation of PP-2B by Ca2+ in the presence
of calmodulin occurs at
300 to 500
nmol/L,20 which is
consistent with our observation that marked inhibition of the
KATP current occurred on increasing
[Ca2+]i from 100 to
300 nmol/L. However, the regulation of PP-2B is complex, and several
accessory proteins and kinases are known to modulate its activity,
including PKC,19 so that the
Ca2+ sensitivity in the intact cell may vary
considerably between different cell types, possibly giving rise to
variable basal KATP channel activity. The
mechanism by which PP-2B would regulate KATP
remains undetermined. Presumably, PP-2B regulates the degree of
phosphorylation of an activation site on either the channel or a
regulatory binding protein required for KATP
channel opening, possibly one targeted by PKA. The situation seems
different in cardiac cells, where the broad-spectrum protein
phosphatase inhibitor, fluoride, had no effect on the
Ca2+-induced inhibition of
KATP channels in excised
patches.28 Moreover, in
renal tubule cells, neither Ca2+ nor PP-2B
affected rundown of KATP channel activity,
whereas PP-2A accelerated this
process.35 This may suggest
either a different KATP channel type or
different channel regulation in smooth muscle. Although no clear role
for PP-2B in regulating KATP channel in other
tissues has been reported, PP-2B does seem to mediate
Ca2+-induced inhibition of L-type
Ca2+ channels in umbilical vein smooth
muscle.17
In conclusion, we have demonstrated in rat aortic smooth muscle cells that Ca2+ is an important regulator of basal KATP channel activity within the physiological [Ca2+]i range and provide evidence that this is mediated via PP-2B. Whether such regulation is specific to vascular smooth muscle remains to be determined. Our data strongly suggest that such a pathway may contribute to the action of vasodilator and vasoconstrictor agents on KATP channels either through kinase or Ca2+ regulation of PP-2B or from the ability of these agents to alter [Ca2+]i levels directly.
| Acknowledgments |
|---|
This study was supported by the Medical Research Council (MRC), UK, and the Special Trustees of the Middlesex and University College Hospitals. L.H.C. is an MRC Senior Research Fellow in Basic Science.
| Footnotes |
|---|
Received May 30, 2000; revision received October 16, 2000; accepted October 17, 2000.
| References |
|---|
|
|
|---|
2. Miyoshi Y, Nakaya Y. Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun. 1991;181:700706.[Medline] [Order article via Infotrieve]
3.
Zhang L, Bonev AD,
Mawe GM, Nelson MT. Protein kinase A mediates activation of
ATP-sensitive K+ currents by CGRP in
gallbladder smooth muscle. Am J
Physiol. 1994;267:G494G499.
4.
Leach RM, Sheehan
DW, Chacko VP, Sylvester JT. Effects of hypoxia on energy state and pH
in resting pulmonary and femoral arterial smooth muscles.
Am J Physiol. 1998;275:L1051L1060.
5. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992;105:429435.[Medline] [Order article via Infotrieve]
6. Bishop BE, Doggrell SA. The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein. J Auton Pharmacol. 1994;14:99108.[Medline] [Order article via Infotrieve]
7.
Mishra SK, Aaronson
PI. A role for a glibenclamide-sensitive, relatively ATP-insensitive
K+ current in regulating membrane potential
and current in rat aorta. Cardiovasc
Res. 1999;44:429435.
8.
Jackson WF. Ion
channels and vascular tone.
Hypertension. 2000;35:173178.
9. Ashcroft SJH, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal. 1990;2:197214.[Medline] [Order article via Infotrieve]
10.
Kajioka S, Oike
M, Kitamura K. Nicorandil opens a calcium-dependent potassium channel
in smooth muscle cells of the rat portal vein.
J Pharmacol Exp Ther. 1990;254:905913.
11. Clapp LH, Gurney AM. Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp Physiol. 1991;76:677693.[Abstract]
12. Clapp LH. Regulation of glibenclamide-sensitive K+ current by nucleotide phosphates in isolated rabbit pulmonary myocytes. Cardiovasc Res. 1995;30:460468.[Medline] [Order article via Infotrieve]
13.
Sanchez M,
Mcmanus OB. Paxilline inhibition of the
-subunit of the
high-conductance calcium-activated potassium channel.
Neuropharmacology. 1996;35:963968.[Medline]
[Order article via Infotrieve]
14.
Nelson MT, Quayle
JM. Physiological roles and properties of potassium channels in
arterial smooth muscle. Am J
Physiol. 1995;268:C799C822.
15. Clapp LH, Tinker A. Potassium channels in the vasculature. Curr Opin Nephrol Hypertens. 1998;7:9198.[Medline] [Order article via Infotrieve]
16. Walsh MP. Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol. 1993;72:919936.
17.
Schuhmann K,
Romanin C, Baumgartner W, Groschner K. Intracellular
Ca2+ inhibits smooth muscle L-type
Ca2+ channels by activation of protein
phosphatase type 2B and by direct interaction with the channel.
J Gen Physiol. 1997;110:503513.
18.
Liang H, Venema
VJ, Wang X, Ju H, Venema RC, Marrero MB. Regulation of angiotensin
II-induced phosphorylation of STAT3 in vascular smooth muscle cells.
J Biol Chem. 1999;274:1984619851.
19.
Herzig S, Neumann
J. Effects of serine/threonine protein phosphatases on ion channels in
excitable membranes. Physiol
Rev. 2000;80:173210.
20. Hemenway CS, Heitman J. Calcineurin: structure, function, and inhibition. Cell Biochem Biophys. 1999;30:115151.[Medline] [Order article via Infotrieve]
21. Perrino BA. Regulation of calcineurin phosphatase activity by its autoinhibitory domain. Arch Biochem Biophys. 1999;372:159165.[Medline] [Order article via Infotrieve]
22. Beech DJ, Zhang H, Nakao K, Bolton TB. K-channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol. 1993;110:573582.[Medline] [Order article via Infotrieve]
23. Zhang HL, Bolton TB. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol. 1996;118:105114.[Medline] [Order article via Infotrieve]
24.
Cole WC, Malcolm
T, Walsh MP, Light PE. Inhibition by protein kinase C of the
KNDP subtype of vascular smooth muscle
ATP-sensitive potassium channel. Circ
Res. 2000;87:112117.
25. Kamouchi M, Kajioka S, Sakai T, Kitamura K, Kuriyama H. A target K+ channel for the LP-805-induced hyperpolarization in smooth muscle cells of the rabbit portal vein. Naunyn-Schmied Arch Pharmacol. 1993;347:329335.[Medline] [Order article via Infotrieve]
26.
Kovacs RJ, Nelson
MT. ATP-sensitive K+ channels from aortic
smooth muscle incorporated into planar lipid bilayers.
Am J Physiol. 1991;261:H1H6.
27. Lorenz JN, Schnermann J, Brosius FC, Briggs JP, Furspan PB. Intracellular ATP can regulate afferent arteriolar tone via ATP-sensitive K+ channels in the rabbit. J Clin Invest. 1992;90:733740.
28. Findlay I. Calcium-dependent inactivation of the ATP-sensitive K+ channel of rat ventricular myocytes. Biochim Biophys Acta. 1988;943:297304.
29. Hehl S, Moser C, Weik R, Neumcke B. Internal Ca2+ ions inactivate and modify ATP-sensitive potassium channels in adult mouse skeletal muscle. Biochim Biophys Acta. 1994;1190:257263.
30. Kwak YG, Park SK, Cho KP, Chae SW. Reciprocal modulation of ATP-sensitive K+ channel activity in rat ventricular myocytes by phosphorylation of tyrosine and serine threonine residues. Life Sci. 1996;58:897904.[Medline] [Order article via Infotrieve]
31. Light PE, Allen BG, Walsh MP, French RJ. Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochem. 1995;34:72527257.[Medline] [Order article via Infotrieve]
32.
Hashimoto Y,
Perrino BA, Soderling TR. Identification of an autoinhibitory domain in
calcineurin. J Biol Chem. 1990;265:19241927.
33. Weidelt T, Isenberg G. Augmentation of SR Ca2+ release by rapamycin and FK506 causes K+-channel activation and membrane hyperpolarization in bladder smooth muscle. Br J Pharmacol. 2000;129:12931300.[Medline] [Order article via Infotrieve]
34.
Bultynck G, De
Smet P, Weidema AF, Ver Heyen M, Maes K, Callewaert G, Parys JB, De
Smedt H. Effects of the immunosuppressant FK506 on intracellular
Ca2+ release and
Ca2+ accumulation mechanisms.
J Physiol (Lond). 2000;525:681693.
35.
Kubokawa M,
Mcnicholas CM, Higgins MA, Wang W, Giebisch G. Regulation of
ATP-sensitive K+ channel by membrane-bound
protein phosphatases in rat principal tubule cell.
Am J Physiol. 1995;269:F355F362.<
This article has been cited by other articles:
![]() |
G. I. Purves, T. Kamishima, L. M. Davies, J. M. Quayle, and C. Dart Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels J. Physiol., July 15, 2009; 587(14): 3639 - 3650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Naesens, D. R. J. Kuypers, and M. Sarwal Calcineurin Inhibitor Nephrotoxicity Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 481 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Jackson Vanishing Act: Protein Kinase C-Dependent Internalization of Adenosine 5'-Triphosphate-Sensitive K+ Channels Hypertension, September 1, 2008; 52(3): 470 - 472. [Full Text] [PDF] |
||||
![]() |
R. I. Jabr, A. J. Wilson, M. H. Riddervold, A. H. Jenkins, B. A. Perrino, and L. H. Clapp Nuclear translocation of calcineurin Abeta but not calcineurin A{alpha} by platelet-derived growth factor in rat aortic smooth muscle Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2213 - C2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Buckley, M. Singer, and L. H. Clapp Role of KATP channels in sepsis Cardiovasc Res, November 1, 2006; 72(2): 220 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Saks, P. Dzeja, U. Schlattner, M. Vendelin, A. Terzic, and T. Wallimann Cardiac system bioenergetics: metabolic basis of the Frank-Starling law J. Physiol., March 1, 2006; 571(2): 253 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Greenwood, J. Ledoux, A. Sanguinetti, B. A. Perrino, and N. Leblanc Calcineurin A{alpha} but Not A{beta} Augments ICl(Ca) in Rabbit Pulmonary Artery Smooth Muscle Cells J. Biol. Chem., September 10, 2004; 279(37): 38830 - 38837. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ledoux, I. Greenwood, L. R Villeneuve, and N. Leblanc Modulation of Ca2+-dependent Cl- channels by calcineurin in rabbit coronary arterial myocytes J. Physiol., November 1, 2003; 552(3): 701 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Ayres, D. W. Carr, D. S. McConnell, R. W. Lieberman, and G. D. Smith Expression and Intracellular Localization of Protein Phosphatases 2A and 2B, Protein Kinase A, A-Kinase Anchoring Protein (AKAP79), and Binding of the Regulatory (RII) Subunit of Protein Kinase A to AKAP79 in Human Myometrium Reproductive Sciences, October 1, 2003; 10(7): 428 - 437. [Abstract] [PDF] |
||||
![]() |
A. J Wilson and L. H Clapp The molecular site of action of KATP channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta Cardiovasc Res, October 1, 2002; 56(1): 154 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Rolland, J.-C. Henquin, and P. Gilon Feedback Control of the ATP-Sensitive K+ Current by Cytosolic Ca2+ Contributes to Oscillations of the Membrane Potential in Pancreatic {beta}-Cells Diabetes, February 1, 2002; 51(2): 376 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, S. Tran, A. Tinker, and L. H. Clapp The Molecular Composition of KATP Channels in Human Pulmonary Artery Smooth Muscle Cells and Their Modulation by Growth Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Amberg, S. D. Koh, B. A. Perrino, W. J. Hatton, and K. M. Sanders Regulation of A-type potassium channels in murine colonic myocytes by phosphatase activity Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2020 - C2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Hayabuchi, C Dart, and N B Standen Evidence for involvement of A-kinase anchoring protein in activation of rat arterial KATP channels by protein kinase A J. Physiol., October 15, 2001; 536(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |